{"schema_version":"1.0","hypothesis_id":1378,"triple":{"drug":"Bevacizumab","drug_canonical":"bevacizumab","mediator":"VEGF","mediator_canonical":"VEGF","outcome":"Vascular dementia","outcome_canonical":"Vascular dementia"},"domain":{"domain":"cross_domain","source":"glioblastoma","target":"alzheimer"},"provenance_completeness":"partial_backfill","completeness_notes":"Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.","source_papers":[{"doi":"10.1038/s41467-026-71362-7","pmid":"41951573","year":2026,"roles":["drug_mediator"],"title":"L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial","journal":"Nat Commun","work_id":112597,"publication_date":"2026-04-08"},{"doi":"10.1002/1545-5017.70059","pmid":"41431343","year":2025,"roles":["drug_mediator"],"title":"Incidence of Bevacizumab‐Associated Toxicity in Children With Low‐Grade Glioma With and Without Neurofibromatosis Type 1","journal":"Pediatr Blood Cancer","work_id":110825,"publication_date":"2025-12-22"},{"doi":"10.1016/j.ijpx.2025.100367","pmid":"40757003","year":2025,"roles":["drug_mediator"],"title":"Developing Immunoniosomes (INs): Antibody and Fab conjugations of niosomal nanoparticles via UV-NBS and EDC/NHS chemistry for treating glioblastoma cells","journal":"Int J Pharm X","work_id":9501,"publication_date":"2025-07-23"},{"doi":"10.1038/s41598-020-79465-x","pmid":"33420169","year":2021,"roles":["drug_mediator"],"title":"Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model","journal":"Sci Rep","work_id":888,"publication_date":"2021-01-08"},{"doi":"10.31031/nacs.2020.04.000596","pmid":"32924014","year":2020,"roles":["drug_mediator"],"title":"Glioblastoma: Targeting Angiogenesis and Tyrosine Kinase Pathways","journal":"Nov Approaches Cancer Study","work_id":6495,"publication_date":"2020-05-29"},{"doi":"10.1186/s13195-018-0385-8","pmid":"29933741","year":2018,"roles":["mediator_outcome"],"title":"Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia","journal":"Alzheimers Res Ther","work_id":69531,"publication_date":"2018-06-22"}],"source_paper_count":6,"extracted_claims":[{"side":"drug_mediator","object":"VEGF","context":"glioblastoma mouse model","subject":"bevacizumab","work_id":888,"claim_id":1415,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":7},{"side":"drug_mediator","object":"VEGF","context":"in glioblastoma","subject":"bevacizumab","work_id":6495,"claim_id":7551,"polarity":"positive","predicate":"inhibits","confidence":0.8,"extraction_run_id":9},{"side":"drug_mediator","object":"VEGF","context":"in immunoniosomes for glioblastoma treatment","subject":"Bevacizumab","work_id":9501,"claim_id":9630,"polarity":"positive","predicate":"binds_to","confidence":0.9,"extraction_run_id":9},{"side":"drug_mediator","object":"VEGF","context":"general mechanism","subject":"Bevacizumab","work_id":110825,"claim_id":85832,"polarity":"positive","predicate":"binds_to","confidence":0.9,"extraction_run_id":19},{"side":"drug_mediator","object":"VEGF","context":"in newly-diagnosed glioblastoma patients after radiotherapy","subject":"bevacizumab","work_id":112597,"claim_id":87419,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":19},{"side":"mediator_outcome","object":"vascular dementia","context":"cerebrospinal fluid","subject":"VEGF","work_id":69531,"claim_id":58336,"polarity":"negative","predicate":"associated_with","confidence":0.9,"extraction_run_id":16}],"extracted_claim_count":6,"extraction":{"model":"deepseek-v4-flash","model_source":"configured","prompt_version":"v1_2026_05_07","run_ids":[7,9,16,19]},"bridge":{"a_to_b_predicate":"binds_to","b_to_c_predicate":"associated_with","a_to_b_evidence_count":5,"b_to_c_evidence_count":1,"edge_support_log_ab":1.791759469228055,"edge_support_log_bc":0.6931471805599453,"novelty_factor":1.0,"direct_a_to_c_count":0},"embedding":{"model":"bge-m3","dim":1024,"max_length":8192,"similarity_scores":{}},"scoring":{"method":"swanson_abc_log_evidence_with_novelty_penalty","formula":"score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)","score_raw":0.24849066497880004,"score":0.24849066497880004,"quality_tier":"mid","quality_reason":null},"pipeline_run":{"id":4,"run_uuid":"eb8b7730-d92e-4cd5-95dd-95f6c5d62cc2","command":"scripts/backfill_provenance_v2.py:v2_2026_05_12","status":"completed","git_commit":"9996ffaa56e9b7cd5f677bd8203624c2c18aa000","host":"MacBook-Pro-Daniel96.local","started_at":"2026-05-12T21:35:53.363326+00:00","ended_at":"2026-05-12T21:43:41.903387+00:00","notes":"Retroactive provenance backfill on 2026-05-13 for snapshot v2_2026_05_12. Synthetic pipeline_runs row — original generation run records are lost (pre-date provenance schema). All recoverable fields populated from current DB state (claims, works, repurposing_hypotheses); pipeline_run record is synthetic, hence completeness='partial_backfill'.\nBackfilled 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.","domains":["als","alzheimer","depression","epilepsy","glioblastoma","inflammatory_bowel_disease","multiple_sclerosis","pancreatic_cancer","rheumatoid_arthritis","type_2_diabetes"]},"generated_at":"2026-05-12T21:43:39.496175+00:00"}